Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cardiovasc. Med.

Sec. Coronary Artery Disease

Volume 12 - 2025 | doi: 10.3389/fcvm.2025.1666458

This article is part of the Research TopicNew Perspectives on Drug-coated Balloons (DCB) For Treatment of Acute and Chronic Coronary Artery DiseaseView all 3 articles

Optical Coherence Tomography Findings after Drug-coated balloon Treatment for De Novo Coronary Artery Lesions with Eruptive Calcified Nodule

Provisionally accepted
Kazuki  MatsudaKazuki Matsuda1Tetsumin  LeeTetsumin Lee1*Takashi  AshikagaTakashi Ashikaga1Toshihiro  NozatoToshihiro Nozato1Yasutoshi  NagataYasutoshi Nagata1Masakazu  KanekoMasakazu Kaneko1Ryoichi  MiyazakiRyoichi Miyazaki1Toru  MisawaToru Misawa1Masashi  NagaseMasashi Nagase1Tomoki  HorieTomoki Horie1Mao  TeruiMao Terui1Daigo  KachiDaigo Kachi1Yuki  OdanakaYuki Odanaka1Maki  OhiraMaki Ohira1Naoya  KikkojiNaoya Kikkoji1Ayaka  KoidoAyaka Koido1Megumi  KouMegumi Kou1Risako  BabaRisako Baba1Akira  TakakumaAkira Takakuma1Taishi  YonetsuTaishi Yonetsu2Tetsuo  SasanoTetsuo Sasano2
  • 1Musashino Red Cross Hospital, Tokyo, Japan
  • 2Tokyo Kagaku Daigaku, Meguro, Japan

The final, formatted version of the article will be published soon.

The purpose of the present study was to investigate the factors associated with worse clinical outcomes in patients with de novo eruptive calcified nodule (CN) lesions after stent-less percutaneous coronary intervention (PCI) with a drug-coated balloon (DCB), as assessed by optical coherence tomography (OCT) and morphological findings at target lesion revascularization (TLR) or during the follow-up period. We retrospectively enrolled 68 de novo eruptive coronary artery eruptive CN lesions in 58 patients who underwent PCI with DCB. All lesions were treated without stents and underwent both pre-and post-PCI OCT. The patients were divided into two groups: those with or without target lesion failure (TLF), defined as a composite of culprit lesion-related cardiac death, myocardial infarction, and TLR. At a median follow-up period of 650 days, TLF events occurred in 14 lesions (20.6%) and were associated with the absence of medial involvement of coronary artery dissection on post-PCI OCT (28.6% vs. 70.4%, P=0.006). In the subgroup analysis of 16 lesions with serial OCT imaging (pre-and post-PCI at the index PCI and at TLR or follow-up), TLR occurred in nine lesions. We found CN protrusion at TLR in seven lesions, layered plaque at TLR in one lesion, and suboptimal lumen expansion at the index PCI in another lesion as restenosis patterns. Moreover, CN protrusion was significantly more frequent in TLR lesions than in the seven non-TLR lesions (77.8% vs. 14.3%, P=0.041). In conclusion, we observed a high incidence of TLF after DCB treatment for de novo eruptive CN coronary artery lesions, which correlated with the absence of medial involvement in dissection. CN protrusion is frequently observed in TLR lesions, whereas late lumen enlargement is predominantly observed in non-TLR lesions.

Keywords: Drug-coated balloon, Calcified nodule, Optical Coherence Tomography, target-lesion failure, Target-lesion revascularization, Coronary Artery Disease

Received: 15 Jul 2025; Accepted: 22 Oct 2025.

Copyright: © 2025 Matsuda, Lee, Ashikaga, Nozato, Nagata, Kaneko, Miyazaki, Misawa, Nagase, Horie, Terui, Kachi, Odanaka, Ohira, Kikkoji, Koido, Kou, Baba, Takakuma, Yonetsu and Sasano. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Tetsumin Lee, ltetsumin@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.